The Valley Desk

Clinical trial reportJournal of the European Academy of Dermatology and Venereology : JEADVPublished

Guselkumab for the treatment of patients with moderate-to-severe hidradenitis suppurativa: A phase 2 randomized study

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Clinical trial report
Venue
Journal of the European Academy of Dermatology and Venereology : JEADV
Published
Subject terms
Humans; Hidradenitis Suppurativa; Psoriasis; Treatment Outcome; Severity of Illness Index; Double-Blind Method; Infant, Newborn; Antibodies, Monoclonal, Humanized
PubMed ID
37317022
Added to directory
Source checked

Report a correction or request removal